Sedation with collateral support for stroke clot removal
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a specific sedation approach, along with support during the procedure, for people having emergency clot removal (mechanical thrombectomy) for a certain type of acute ischemic stroke. It may help make the procedure safer and more effective by improving how patients are managed during endovascular treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- Your stroke is an ischemic stroke from a blocked large vessel in the front of the brain (ICA, M1, or M2)
- You have a high enough stroke severity on a neurologic exam (NIHSS) and meet the trial’s brain-scan timing/mismatch rules
- You were doing well before the stroke (no more than mild disability; mRS 0–2)
- A doctor believes you can safely get mechanical thrombectomy soon (planned groin puncture within 24 hours of last known well, and within 90 minutes of arriving to the ER)
- Your brain imaging does not show bleeding, major mass/tumor, or too large an established infarct core
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different types of anesthesia given during mechanical thrombectomy (clot removal) for people who have a severe ischemic stroke from a large artery blockage. Researchers want to see which anesthesia approach leads to better recovery.
This study compares different ways of giving sedation during a procedure to remove blood clots in strokes caused by blocked vertebral or basilar arteries. The goal is to see which sedation approach is safest and works best for patients undergoing endovascular treatment.
This trial tests a new catheter (Super-Bore 8/7F) to remove blood clots in people having a major stroke caused by a blocked large artery in the brain. The goal is to see if it is safe and effective at restoring blood flow when used within 24 hours of stroke symptoms starting.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests giving a clot-dissolving medicine (rhPro-UK) through a vein before a procedure to remove a large blood clot in the brain. It is for people who had a stroke 4.5 to 24 hours ago and are already scheduled for clot removal. The goal is to see if the medicine helps improve blood flow and outcomes.
This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.
Hear when a new Acute Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.